Novo Nordisk
NVO
#78
Rank
A$320.16 B
Marketcap
A$72.05
Share price
-0.27%
Change (1 day)
-56.60%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2025 : A$40.21 Billion

According to Novo Nordisk's latest financial reports the company has A$40.21 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$32.18 B38.95%
2023-12-31$A$23.16 B31.12%
2022-12-31$A$17.66 B18.92%
2021-12-31$A$14.85 B9.14%
2020-12-31$A$13.61 B10.38%
2019-12-31$A$12.33 B9.4%
2018-12-31$A$11.27 B9.6%
2017-12-31$A$10.28 B15.68%
2016-12-31$A$8.89 B-5.89%
2015-12-31$A$9.44 B17.5%
2014-12-31$A$8.04 B-8.99%
2013-12-31$A$8.83 B27.45%
2012-12-31$A$6.93 B8.97%
2011-12-31$A$6.36 B-2.03%
2010-12-31$A$6.49 B-15.25%
2009-12-31$A$7.66 B-12.91%
2008-12-31$A$8.79 B21.99%
2007-12-31$A$7.21 B6.43%
2006-12-31$A$6.77 B13.5%
2005-12-31$A$5.97 B-4.89%
2004-12-31$A$6.27 B9.08%
2003-12-31$A$5.75 B-8.66%
2002-12-31$A$6.30 B3.27%
2001-12-31$A$6.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$140.15 B 248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$35.90 B-10.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.00 B-30.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$129.92 B 223.03%๐Ÿ‡ซ๐Ÿ‡ท France